ABSTRACT Three separate experiments were conducted to study the effects of whole yeast cell product supplementation in pullets and layer hens. Body weight gain, fecal and intestinal coccidial oocyst counts, cecal microflora species, cytokine mRNA amounts, and CD4 + and CD8 + T-cell populations in the cecal tonsils were analyzed following an experimental coccidial infection. In Experiment I, day-old Leghorn layer chicks were fed 3 experimental diets with 0, 0.1, or 0.2% whole yeast cell product (CitriStim R , ADM, Decatur, IL). At 21 d of age, birds were challenged with 1 × 10 5 live coccidial oocysts. Supplementation with whole yeast cell product decreased the fecal coccidial oocyst count at 7 (P = 0.05) and 8 (P < 0.01) d post-challenge. In Experiment II, 27-week old Leghorn layer hens were fed 3 experimental diets with 0, 0.05 or 0.1% whole yeast cell product and challenged with 1 × 10 5 live coccidial oocysts on d 25 of whole yeast cell product feeding.
INTRODUCTION
Yeast cell products are derived from yeast species such as Saccharomyces cerevisiae and Pichia guillermondii (Solis de los Santos et al., 2007; Shanmugasundaram and Selvaraj, 2012) . The yeast cell wall contains the polysaccharides mannan oligosaccharides and β-glucans (Lipke and Ovalle, 1998) . These polysaccharides can have immunomodulatory effects in several species, including poultry . Yeast products have become important in the poultry industry for their anticoccidial potential, especially due to concerns with antimicrobial drug resistance in pathogens (Gustafson and Bowen, 1997) . Coccidiosis is a major disease in the poultry industry caused by protozoan parasites of the genus Eimeria (Dalloul and Lillehoj, 2006) . Eimeria parasites cause lesions that impair the intestinal epithelia, thereby increasing susceptibility to intestinal infections in chickens and leading to severe economic losses in the poultry industry (Dalloul and Lillehoj, 2006) . The 1,3/1,6-β-glucans are glucose polymers that form the structural components in the cell wall of yeast (Cox et al., 2010) . The 1,3/1,6-β-glucans stimulate immune cells by resembling pathogen-associated molecular patterns (PAMPs). The β-glucan PAMPs are recognized by the receptor dectin-1 on macrophages. This recognition signals dectin-1 receptor and tolllike receptor 2 mediated pathways and activates a cascade system leading to the production of proinflammatory cytokines and chemokines (Brown and Gordon, 2003) .
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Research on β-glucan and mannan oligosaccharide supplementation in layer pullets and hens has been more limited compared to broilers. Yalcin et al. (2010) observed that yeast product supplemented to layer hens for 16 wk enhanced humoral immune response. Several studies have shown that β-glucan supplementation in broilers enhances cell-mediated and humoral immune responses (Chae et al., 2006; Cox et al., 2010) . Cox et al. (2010) observed that broilers supplemented with β-glucan resulted in decreased intestinal coccidial lesion severity 14 d post-coccidial challenge. Elmusharaf et al. (2007) observed that mannan oligosaccharide supplementation minimized coccidial infection in broilers. Mannan oligosaccharides can deter adhesion and colonization of harmful bacteria such as Salmonella and E. coli (Becker and Galletti, 2008) . These bacteria have type-1 fimbriae that can adhere to mannan oligosaccharides within the intestines as opposed to the host's enterocytes (Badia et al., 2013) . A decrease in harmful bacteria results in increased proportion of beneficial bacteria due to less competition within the intestines (Guarner and Malagelada, 2003) . Beneficial bacteria in the intestines increases intestinal villi length and integrity of intestinal wall, thereby enhancing the intestinal health and protection against coccidia (Hooge, 2004) . Shanmugasundaram et al. (2013) previously studied the effects of whole yeast cell product supplementation post-coccidial challenge in broiler chickens, and identified that whole yeast cell product supplementation can improve production parameters, decrease fecal oocyst counts and increase inflammatory cytokine (interleukin [IL]-1β) production post-coccidial infection. However, because layer hens raised in cage-free environments is increasing in the United States, it is becoming crucial to study the effects of yeast products in layer hens challenged with coccidiosis, in addition to broilers (Ahammed et al., 2014) . Layer hens raised on litter as opposed to cages have higher rates of coccidiosis (Fossum et al., 2009) . Koenen et al. (2002) observed that layer chickens and broilers differ in immune responses against antigens, most likely due to being genetically bred for different traits over many years. The present experiments were conducted to study the effects of whole yeast cell product supplementation on body weight gain, fecal and intestinal coccidial oocyst counts, cecal microflora species, cytokine expression in cecal tonsils, and CD4 + and CD8 + T-cell populations following an experimental coccidial infection in unvaccinated layer pullets and layer hens.
MATERIALS AND METHODS
Three separate experiments were conducted to analyze the effects of whole yeast cell product supplementation on intestinal immune parameters during an experimental coccidial infection model. All animal protocols were approved by the Institutional Animal Care and Use Committee at The Ohio State University or the Agricultural and Animal Care and Use Committee at Archer Daniel Midland Company.
Coccidiosis Experiment I
Experimental Layout. Day-old White Leghorn pullets (36 birds in total) were randomly distributed to one of 3 dietary treatments with 0, 0.1, or 0.2% whole yeast cell product (CitriStim R , ADM, Decatur, IL). The basal diet was based on corn and soybean meal. After 21 d of yeast product supplementation, the birds were weighed individually to identify birds of similar sizes to be used in the coccidial challenge. Birds (n = 6) were placed in individual battery cages in a completely randomized design. The experimental design was a 3 (diets) by 2 (healthy or coccidial infection) factorial arrangement. Each treatment had 6 replicate cages for a total of 36 cages used in the experiment.
Coccidial Challenge and Body Weight Gain. At 21 d of age, 6 birds from each dietary treatment (0, 0.1 or 0.2% whole yeast cell product) were orally gavaged with 1 × 10 5 live coccidial oocysts (Inovocox, Pfizer Animal Health, NY) in 200 μL PBS (Annamalai and Selvaraj, 2012) . The live coccidial oocysts were obtained from Inovocox EM1 live coccidiosis vaccine and consisted of Eimeria acervulina, E. maxima, and E. tenella. The challenge was approximately 100 times the recommended dose of the Inovocox EM1 coccidiosis vaccine. The birds were weighed individually at 0 and 9 d postcoccidial challenge to analyze body weight gain because decreased body weight is a common symptom in chickens with coccidial infection (Kaboudi et al., 2016) .
Effect of Whole Yeast Cell Product Supplementation on Fecal Coccidial Oocyst Count. Feces were collected daily from 6 battery cages per treatment (n = 6) from d 6 through 9 post-coccidial challenge. The fecal coccidial oocysts were counted using a salt-floatation technique and analyzed for the total number of coccidial oocysts using a McMaster chamber (Annamalai and Selvaraj, 2012) .
Effect of Whole Yeast Cell Product on CD4 + and CD8 + Cell Percentages in the Cecal Tonsils. Total CD4 + and CD8 + cell percentages in cecal tonsils were analyzed. At 9 d post-coccidial challenge, cecal tonsils were collected. Cells were collected from cecal tonsils using a 0.45 μm cell strainer (Fisher Scientific). Cells from each sample were placed into 5 mL of RPMI, centrifuged at 400 × g for 5 min, resuspended and centrifuged again at 400 × g for 5 min. Cells were then resuspended in wash buffer (1× PBS, 2 mM EDTA, 1.5% FBS) at a concentration of 10 6 cells per well. For CD4 + /CD8 + plate, 10 6 cells were added to each well containing CD4 + (1:200 dilution) and CD8 + (1:450 dilution) and then incubated for 20 min at 4 • C. Plates were then centrifuged at 400 × g for 3 min. Cells were washed 3 times and then analyzed by flow cytometry using cytosoft software (Guava Easycyte, Millipore, Billerica, MA) as described previously by Shanmugasundaram and Selvaraj (2012).
Experiment II
Experimental Layout. In Experiment II, a total of 90 White Leghorn layer hens (27 wk of age) were used in a completely randomized design. There were 6 treatments in a factorial arrangement of 3 diets by the inclusion of 0, 0.05, or 0.1% whole yeast cell product (CitriStim R , ADM, Decatur, IL) by 2 health status (healthy vs. coccidial infection). The basal diet was based on corn and soybean meal. The experimental unit was the bird caged individually. Birds were supplemented with yeast product beginning at 27 wk of age, and continued supplementation throughout entire length of the experiment. On d 25 of whole yeast cell product feeding, birds were challenged with either PBS or 1 × 10 5 live coccidial oocysts (Inovocox, Pfizer Animal Health, NY) in 200 μL PBS (Annamalai and Selvaraj, 2012) . The live coccidial oocysts were from Inovocox EM1 live coccidiosis vaccine and consisted of Eimeria acervulina, E. maxima, and E. tenella. On d 5, 13, and 38 post-challenge, 5 birds per treatment were euthanized to harvest samples. Animal husbandry and coccidial challenge protocols were similar to Coccidiosis Experiment I.
Effect of Whole Yeast Cell Product Supplementation on Coccidial Oocyst Count in Intestinal Content. At 5, 13, and 38 d post-coccidial challenge, intestinal content were collected, enriched for coccidial oocysts using a salt-floatation technique and analyzed for total number of coccidial oocysts using a McMaster chamber (Annamalai and Selvaraj, 2012) . The time points for coccidial oocyst sampling were chosen to analyze infection during early infection, late infection and clearance of infection (Allen and Fetterer, 2002) .
Effect of Whole Yeast Cell Product Supplementation on Gut Microflora. At 5, 13 and 38 d postcoccidial challenge, cecal content was collected. Cecal content (0.2 g per sample) were diluted in 10 mL of sterile PBS and centrifuged at 14,500 × g for 2 min to remove debris. The resulting pellet was then resuspended in 450 μL of 50 mM EDTA and treated with 50 μL of lysozyme (20 mg/mL) for 45 min at 37
• C. After incubation, samples were centrifuged at 14,500 × g for 2 min and supernatant discarded. Samples were then treated with 600 μL of lysis buffer and 32 μL of proteinase K (20 mg/mL) for 5 min at 80
• C; 6 M NaCl and isopropanol were added to the cell lysate and centrifuged at 14,500 × g for 2 min. DNA pellets were resuspended and washed in 70% ethanol and then resuspended in 75 to 100 μL of TE buffer. Extracted DNA samples were stored at -20
• C (Amit- Romach et al., 2004) . Cecal microflora was analyzed by real-time polymerase chain reaction (PCR) as described earlier (Selvaraj et al., 2010) .
Primers for Lactobacillus, Bifidobacterium, and Universal primers (primers that identify all known bacteria) were adapted from an earlier publication (AmitRomach et al., 2004). The threshold cycle (Ct) values were determined by iQ5 software (Bio-Rad, Hercules, CA) when the fluorescence rises exponentially 2-fold above background. The Ct values for Lactobacillus, Bifidobacterium, and Salmonella were normalized to the Ct values of the Universal primers. Relative proportions of each bacteria were evaluated by expressing all Ct values relative to the Ct value of the Universal primers. The proportions of each bacterial group are presented where the total of the examined bacteria was set at 100% as described previously (Amit-Romach et al., 2004) . Bacterial primers are described in Table 1 .
Effect of Whole Yeast Cell Product Supplementation on CD4
+ and CD8 + Cell Percentages in the Cecal Tonsils. At 5, 13, and 38 d post-coccidial challenge, cecal tonsils were collected. CD4
+ and CD8 + cell percentages were analyzed as described in Experiment I.
Effect of Whole Yeast Cell Product Supplementation on IL-1β and IL-10 mRNA Expression in the Cecal Tonsils. At 5, 13, and 38 d post-coccidial challenge, total RNA was collected from cecal tonsils. RNA was then reverse transcribed into cDNA (Selvaraj and Klasing, 2006) . The mRNA was analyzed for inflammatory IL-1β and anti-inflammatory IL-10 by real-time PCR (iCycler, BioRad, Hercules, CA) using SyBr green after normalizing for β-actin mRNA. Primers are described in Table 1 . The annealing temperature for IL-10 was 57.5
• C, for IL-1β was 57
• C, and for β-actin was 57
• C. Fold change from the reference was calculated using the comparative Ct method so that 2 (Ct Sample -Housekeeping) /2 (Ct Reference -Housekeeping) , where Ct is the threshold cycle (Schmittgen and Livak, 2008) . The Ct was determined by iQ5 software (Biorad) when the fluorescence rises exponentially 2-fold above the background.
Experiment III
Experimental Layout A total of 90 White Leghorn layer hens (32 wk of age) were used in a completely randomized design. There were 6 treatments in a factorial arrangement of 3 diets by the inclusion of 0, 0.1, or 0.2% whole yeast cell product (CitriStim R , ADM, Decatur, IL) by 2 health status (healthy vs. coccidial infection). The experimental unit was the bird caged individually. Birds were supplemented with yeast product beginning at 32 wk of age, and continued supplementation throughout entire length of the experiment. On d 66 of whole yeast cell product feeding, birds were challenged with either PBS or 1 × 10 5 live coccidial oocysts (Inovocox, Pfizer Animal Health, NY) in 200 μL PBS (Annamalai and Selvaraj, 2012) . The live coccidial oocysts were from Inovocox EM1 coccidiosis vaccine and consisted of Eimeria acervulina, E. maxima, and E. tenella. On d 5 and 10 postchallenge, 5 birds per treatment were euthanized to harvest samples. Animal husbandry and coccidial Effect of Whole Yeast Cell Product Supplementation on Gut Microflora. At 5 and 10 d post-coccidial challenge, cecal content was collected and analyzed for cecal microflora by real-time PCR as described in Experiment II.
Effect of Whole Yeast Cell Product Supplementation on IL-1β and IL-10 mRNA Expression in the Cecal Tonsils. At 5 and 10 d post-coccidial challenge, total RNA was collected from cecal tonsils for analysis of inflammatory IL-1β and antiinflammatory IL-10 by real-time PCR as described in Experiment II.
Statistical Analysis
A 2-way ANOVA (JMP, SAS, Cary, NC) was used to examine the effect of whole yeast cell product supplementation on dependent variables. When interaction effects between yeast supplementation and challenge were significant (P < 0.05), differences between means were analyzed by Tukey's least square means comparison.
RESULTS

Effect of Whole Yeast Cell Product Supplementation on Body Weight Gain Post-coccidial Challenge
Supplementation of whole yeast cell product did not (P > 0.05) significantly affect body weight gain postcoccidial challenge in Experiments I, II, and III. 
Effect of Whole Yeast Cell Product Supplementation on Fecal and Intestinal Oocyst Count Post-coccidial Challenge
In Experiment I, supplementation with whole yeast cell product decreased the fecal coccidial oocyst count at d 7 (P = 0.05) and 8 (P < 0.01) post-coccidial challenge (Figure 1) . In Experiment II, supplementation with whole yeast cell product decreased the intestinal content coccidial oocyst count (P < 0.01) at 5, 13, and 38 d post-coccidial challenge compared to the group with no whole yeast cell product supplementation (Figure 2) . In Experiment III, supplementation of 
Effect of Whole Yeast Cell Product Supplementation on Microflora Species in the Cecal Content
In the absence of a coccidial infection, supplementation with whole yeast cell product increased relative proportion of Lactobacillus (P = 0.03) compared to the control at 5 and 13 d post-challenge time points in Experiment II (Figures 4 and 5) . In Experiment II, supplementation with whole yeast cell product increased rel- . The relative proportion of Lactobacillus in the cecal content was measured by real-time PCR after normalizing to the total DNA content of the cecal content. The proportion of Lactobacillus is presented where the total of the examined bacteria was set at 100%. Bars (+ SEM) without a common superscript differ significantly within 1 d (P < 0.05; n = 5). P values YCW P = 0.15, Cocci P = 0.87, YCW X Cocci P = 0.03. ative proportion of Lactobacillus (P < 0.01) compared to the control group supplemented with 0% whole yeast cell product at 13 d post-coccidial challenge (Figure 4) . Supplementation with whole yeast cell product did not alter relative proportion of Lactobacillus (P > 0.05) compared to the control in challenged birds at 5 d post- 5 live coccial oocysts (treatment). The relative proportion of Lactobacillus in the cecal content was measured by real-time PCR after normalizing to the total DNA content of the cecal content. The proportion of Lactobacillus is presented where the total of the examined bacteria was set at 100%. Bars (+ SEM) without a common superscript differ significantly within 1 d (P < 0.05; n = 5). P values YCW P = 0.05, Cocci P = 0.03, YCW X Cocci P < 0.01. coccidial challenge. Supplementation with whole yeast cell product did not alter (P > 0.05) Bifidobacterium populations.
In Experiment III, supplementation with whole yeast cell product did not alter relative proportion of Lactobacillus or Bifidobacterium (P > 0.05) compared to the control at 5 or 10 d post-coccidial challenge.
Effect of Whole Yeast Cell Product Supplementation on IL-1β and IL-10 mRNA Expression in the Cecal Tonsils Post-coccidial Challenge
In Experiment II, supplementation with whole yeast cell product had no significant effect on inflammatory cytokine IL-1β in the cecal tonsils. In the absence of an infection, 0.05% and 0.1% whole yeast cell product supplementation up-regulated (P = 0.04) antiinflammatory cytokine IL-10 mRNA expression in the cecal tonsils at 13 d post-coccidial time point (Figure 6) .
In Experiment III, supplementation with whole yeast cell product had no significant effect on inflammatory cytokine IL-1β in the cecal tonsils at 5 and 10 d post-coccidial challenge. Whole yeast cell product supplementation at 0.2% down-regulated (P = 0.01) anti-inflammatory cytokine IL-10 mRNA expression in the cecal tonsils at the 5 d post-coccidial challenge (Figure 7) . 5 live coccial oocysts (treatment). mRNA amount was analyzed by real time PCR, correct for β-Actin and normalized to the mRNA content for the uninfected birds so all bars represent fold change compared to the control group. Bars (+ SEM) without a common superscript differ significantly within 1 d (P < 0.05; n = 5). P values YCW P = 0.11, Cocci P < 0.01, YCW X Cocci P = 0.04.
DISCUSSION
Three separate experiments were conducted to analyze the effects of whole yeast cell product supplementation on body weight, fecal and intestinal content coccidial oocyst count, cecal bacterial species, inflammatory and anti-inflammatory cytokine amounts in the cecal tonsils, and CD4
+ and CD8 + cell proportions in the cecal tonsils following an experimental coccidial infection in unvaccinated growing pullets and layer chickens. Our experiments observed that whole yeast cell product supplementation in layer pullets and hens decreased fecal and intestinal content oocyst count, increased relative proportions of Lactobacillus in the cecal tonsils, regulated anti-inflammatory cytokine IL-10 mRNA expression and decreased CD4 + and CD8
+ cell percentages in the cecal tonsils postcoccidial challenge.
Prebiotics effect on body weight gain has varied in chickens, and research in body weight gain is more limited for layers than broilers. Yalcinkaya et al. (2008) observed that day-old broilers supplemented with 0.05%, 0.10%, or 0.15% mannan oligosaccharides for 42 d showed no significant difference in body weight gain. However, Kim et al. (2011) observed that day-old broilers supplemented with 0.025% or 0.05% mannan oligosaccharides for 4 wk had a significant increase in body weight gain. Varying results may be due to the yeast concentration and duration of supplementation.
Our results showed that whole yeast product decreased fecal and intestinal oocyst count in layer pullets supplemented with a concentration of 0.1 or 0.2% yeast product, and in layer hens supplemented with a concentration of 0.05 or 0.1% yeast product. Broiler chickens supplemented with mannan oligosaccharides and challenged with Eimeria tenella observed reduced oocyst excretion compared to the control, indicating that mannan oligosaccharides may have anticoccidial characteristics (Elmusharaf et al., 2007) . The anticoccidial effect of the yeast cell wall may be due to the ability of β-glucan and mannan oligosaccharides to stimulate the immune system (Brown and Gordon, 2003; GomezVerduzco et al., 2009) . Furthermore, mannan oligosaccharides can improve epithelial integrity and uniformity in the intestines, acting as a stronger barrier against infection (Hooge, 2004) .
Our results observed that the whole yeast product increased Lactobacillus species, but had no significant effect in Bifidobacterium species in the cecum. Yeast cell products have prebiotic properties, as they are nondigestible carbohydrates that stimulate the growth of beneficial bacteria within the intestines of the host (Lee et al., 2016) . The fermentation of prebiotics by beneficial bacteria such as Lactobacillus and Bifidobacterium produces volatile fatty acids, which promote epithelial cell proliferation, enhancing the integrity of the intestinal wall, which further protects against pathogenic infections such as coccidiosis (Macfarlane et al., 2008) .
Mannan oligosaccharides supplemented to broilers at concentrations of both 0.025% and 0.05% have previously resulted in an increase in Lactobacillus species in the ileum (Kim et al., 2011) . Shanmugasandaram et al. (2013) observed no significant difference in Lactobacillus or Bifidobacterium in cecal content of broilers supplemented with 0.1% or 0.2% yeast cell wall product. Variations in the effects of prebiotics on intestinal beneficial bacteria may be due to duration of supplementation and concentration of prebiotics. In our experiments, it appears that lower concentrations of yeast product (0.05% or 0.1%) may have been more beneficial in mature layers, as seen in the increase in Lactobacillus in Experiment II compared to Experiment III. We plan to conduct future studies to assess the optimal dose of whole yeast product to increase intestinal beneficial bacteria.
The results of these experiments show a significant decrease in CD8 + cell percentages in the cecal tonsils at 5 d post-coccidial challenge. Studies have shown that T cells in gut-associated lymphoid tissues are the main effectors in primary and challenge coccidial infections (Lillehoj and Trout, 1996) . CD8 + T cells increase in primary coccidial infections in chickens (Lillehoj and Trout, 1996) . A decrease in CD8 + T cells significantly decreased oocysts during primary infections of both E. acervulina and E. tenella (Allen and Fetterer, 2002) . Because our CD4 + and CD8 + T cell percentage analysis is limited in explaining the cell-mediated response in our experiments, we found it necessary to analyze inflammatory and anti-inflammatory cytokine expression in the cecal tonsils for additional data.
The current study observed a down-regulation of the anti-inflammatory cytokine IL-10 in layer hens supplemented with 0.2% yeast product, and an up-regulation of IL-10 in layer hens supplemented with 0.05% and 0.1% yeast product. Yeast cell product supplementation has previously shown to stimulate immune response in chickens. For example, yeast product supplemented to day-old broilers for 4 wk resulted in a decrease in IL-10 expression in the cecal tonsils (Munyaka et al., 2012) . Shanmugasundaram et al. (2013) observed up-regulation of IL-β in birds challenged with coccidiosis and supplemented with 0.2% yeast cell product. The concentration of yeast cell product in the diet and the severity of coccidial infection may play a role in cytokine expression differences in chickens. For future studies, it will be beneficial to carry out experiments optimizing the most effective concentration of yeast product against coccidial infection in layers.
It could be concluded from these experiments that supplementing whole yeast cell product can decrease fecal and intestinal oocyst count, increase cecal Lactobacillus, modulate IL-10 mRNA expression in the cecal tonsils and decrease CD8 + T-cell percentages in the cecal tonsils post-coccidial infection in pullets and layer hens.
